216 related articles for article (PubMed ID: 35117882)
1. Development and validation of a nomogram for predicting survival in patients with non-metastatic primary adenocarcinoma of the bladder.
Yu DD; Dong H; Chen WK; Chen K; Wu ZG; Li CD; Cai J; Xiao YB
Transl Cancer Res; 2020 Sep; 9(9):5155-5165. PubMed ID: 35117882
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a nomogram to predict survival in patients with metastatic testicular germ cell tumors.
Yu DD; Hui D; Chen WK; Xiao YB; Wu ZG; Wang QQ; Zhou CF; Chen ZX; Li CD; Cai J
Transl Cancer Res; 2020 Apr; 9(4):2402-2415. PubMed ID: 35117600
[TBL] [Abstract][Full Text] [Related]
3. A convenient clinical nomogram for predicting the cancer-specific survival of individual patients with small-intestine adenocarcinoma.
Wang N; Yang J; Lyu J; Liu Q; He H; Liu J; Li L; Ren X; Li Z
BMC Cancer; 2020 Jun; 20(1):505. PubMed ID: 32487033
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a nomogram for predicting cancer-specific survival in patients with Wilms' tumor.
Pan Z; You H; Bu Q; Feng X; Zhao F; Li Y; Lyu J
J Cancer; 2019; 10(21):5299-5305. PubMed ID: 31602280
[No Abstract] [Full Text] [Related]
5. Development and validation of a prognostic nomogram for predicting cancer-specific survival in patients with metastatic clear cell renal carcinoma: A study based on SEER database.
Huang G; Liao J; Cai S; Chen Z; Qin X; Ba L; Rao J; Zhong W; Lin Y; Liang Y; Wei L; Li J; Deng K; Li X; Guo Z; Wang L; Zhuo Y
Front Oncol; 2022; 12():949058. PubMed ID: 36237316
[TBL] [Abstract][Full Text] [Related]
6. Construction of novel predictive tools for post-surgical cancer-specific survival probability in patients with primary chondrosarcoma and external validation in Chinese cohorts: a large population-based retrospective study.
Jiang L; Gong Y; Jiang J; Zhao D
J Cancer Res Clin Oncol; 2023 Nov; 149(14):13027-13042. PubMed ID: 37466790
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Prognostic Model to Predict the Prognosis of Patients With Retroperitoneal Liposarcoma: A Large International Population-Based Cohort Study.
Li Y; Wu G; Zhang Y; Yang W; Wang X; Duan L; Niu L; Chen J; Zhou W; Liu J; Zhong H; Fan D; Hong L
Front Oncol; 2022; 12():857827. PubMed ID: 35719991
[TBL] [Abstract][Full Text] [Related]
8. Cancer-specific survival and metastasis in pancreatic mucinous cystadenocarcinoma: A SEER-based cohort study.
Wang R; Su D; Liu Y; Qiu J; Cao Z; Yang G; Luo W; Tao J; Zhang T
Front Oncol; 2022; 12():985184. PubMed ID: 36338678
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a Prognostic Nomogram for Predicting Cancer-Specific Survival in Patients With Lymph Node Positive Bladder Cancer: A Study Based on SEER Database.
Zhan X; Jiang M; Deng W; Liu X; Chen L; Fu B
Front Oncol; 2022; 12():789028. PubMed ID: 35186736
[TBL] [Abstract][Full Text] [Related]
10. Establishment and Verification of a Nomogram for Predicting Survival in Patients with Small Intestinal Gastrointestinal Stromal Tumors.
Lu G; Li J; Wu L; Shi Y; Zhang X; Xia Y; Li L
Dig Dis; 2022; 40(1):50-61. PubMed ID: 33752202
[TBL] [Abstract][Full Text] [Related]
11. A Nomogram for Predicting Cancer-Specific Survival of Osteosarcoma and Ewing's Sarcoma in Children: A SEER Database Analysis.
Wang J; Zhanghuang C; Tan X; Mi T; Liu J; Jin L; Li M; Zhang Z; He D
Front Public Health; 2022; 10():837506. PubMed ID: 35178367
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a Surveillance, Epidemiology, and End Results (SEER)-based prognostic nomogram for predicting survival in gastric cancer with multi-organ metastases.
Wang T; Liu C; Wang W; Huang B; Yu R; Huang M; Dong W
Transl Cancer Res; 2022 Jun; 11(6):1534-1551. PubMed ID: 35836507
[TBL] [Abstract][Full Text] [Related]
13. A novel nomogram predicting cancer-specific survival in small cell lung cancer patients with brain metastasis.
Rong YT; Zhu YC; Wu Y
Transl Cancer Res; 2022 Dec; 11(12):4289-4302. PubMed ID: 36644187
[TBL] [Abstract][Full Text] [Related]
14. Analysis of prognostic factors and establishment of prediction model of lung adenocarcinoma based on SEER database.
He J; Hu Q
Transl Cancer Res; 2023 Dec; 12(12):3346-3359. PubMed ID: 38197071
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:A population-based study.
Yang Z; Bai Y; Liu M; Hu X; Han P
Cancer Med; 2020 Dec; 9(24):9303-9314. PubMed ID: 33063464
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a nomogram to predict postoperative cancer-specific survival of patients with nonmetastatic T3a renal cell carcinoma.
Guo P; Wang Y; Han Y; Wei D; Zhao J; Li M; Jiang Y; Luo Y
Urol Oncol; 2021 Dec; 39(12):835.e19-835.e27. PubMed ID: 34620554
[TBL] [Abstract][Full Text] [Related]
17. A Web-Based Prediction Model for Cancer-Specific Survival of Middle-Aged Patients With Non-metastatic Renal Cell Carcinoma: A Population-Based Study.
Tang J; Wang J; Pan X; Liu X; Zhao B
Front Public Health; 2022; 10():822808. PubMed ID: 35284377
[TBL] [Abstract][Full Text] [Related]
18. A novel clinical tool to predict cancer-specific survival in patients with primary pelvic sarcomas: A large population-based retrospective cohort study.
Huang C; Su Q; Ding Z; Zeng W; Zhou Z
Cancer Med; 2023 Jan; 12(2):1279-1292. PubMed ID: 35796258
[TBL] [Abstract][Full Text] [Related]
19. Survival nomogram for high-grade bladder cancer patients after surgery based on the SEER database and external validation cohort.
Li Y; Chen T; Fu B; Luo Y; Chen L
Front Oncol; 2023; 13():1164401. PubMed ID: 37397381
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of Prognostic Nomograms to Predict Overall and Cancer-Specific Survival for Patients with Adenocarcinoma of the Urinary Bladder: A Population-Based Study.
Yang Z; Bai Y; Liu M; Hu X; Han P
J Invest Surg; 2022 Jan; 35(1):30-37. PubMed ID: 32851885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
